Brittany L. Kmush

Brittany L. Kmush

Auto-generated profile, based on publicly available information

Brittany L. Kmush

Affiliation Department of Public Health, Syracuse University, Syracuse, New York, United States of America

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2014 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
KRKara E. Rudolph
Kara E. Rudolph
JLJustin Lessler
Justin Lessler
RMRachael M. Moloney
Rachael M. Moloney
BKBrittany Kmush
Brittany Kmush
DCDerek A. T. Cummings
Derek A. T. Cummings
Mosquito-borne viruses are a major public health threat, but their incubation periods are typically uncited, non-specific, and not based on data. We systematically review the published literature on six mosquito-borne viruses selected for their public health importance: chikungunya, dengue, Japanese encephalitis, Rift Valley fever, West Nile, and yellow fever viruses. For each, we identify the literature's consensus on the incubation period, evaluate the evidence for this consensus, and provide detailed estimates of the incubation period and distribution based on published experimental and observational data. We abstract original data as doubly interval-censored observations. Assuming a log-normal distribution, we estimate the median incubation period, dispersion, 25th and 75th percentiles by maximum likelihood. We include bootstrapped 95% confidence intervals for each estimate. For West Nile and yellow fever viruses, we also estimate the 5th and 95th percentiles of their incubation periods.

1 May 2021 in Water Research X
Verified
Journal Article
Open access
MWMaxwell L. Wilder
Maxwell L. Wilder
FMFrank Middleton
Frank Middleton
DLDavid Larsen
David Larsen
QDQian Du
Qian Du
AFAriana Fenty
Ariana Fenty
HGHyatt C. Green
Hyatt C. Green
Wastewater surveillance of SARS-CoV-2 RNA is increasingly being incorporated into public health efforts to respond to the COVID-19 pandemic. In order to obtain the maximum benefit from these efforts, approaches to wastewater monitoring need to be rapid, sensitive, and relatable to relevant epidemiological parameters. In this study, we present an ultracentrifugation-based method for the concentration of SARS-CoV-2 wastewater RNA and use crAssphage, a bacteriophage specific to the human gut, to help account for RNA loss during transit in the wastewater system and sample processing. With these methods, we were able to detect, and sometimes quantify, SARS-CoV-2 RNA from 20 mL wastewater samples within as little as 4.5 hours. Using known concentrations of bovine coronavirus RNA and deactivated SARS-CoV-2, we estimate recovery rates of approximately 7-12% of viral RNA using our method. Results from 24 sewersheds across Upstate New York during the spring and summer of 2020 suggested that stronger signals of SARS-CoV-2 RNA from wastewater may be indicative of greater COVID-19 incidence in the represented service area approximately one week in advance. SARS-CoV-2 wastewater RNA was quantifiable in some service areas with daily positives tests of less than 1 per 10,000 people or when weekly positive test rates within a sewershed were as low as 1.7%. crAssphage DNA concentrations were significantly lower during periods of high flow in almost all areas studied. After accounting for flow rate and population served, crAssphage levels per capita were estimated to be about 1.35 × 1011 and 2.42 × 108 genome copies per day for DNA and RNA, respectively. A negative relationship between per capita crAssphage RNA and service area size was also observed likely reflecting degradation of RNA over long transit times. Our results reinforce the potential for wastewater surveillance to be used as a tool to supplement understanding of infectious disease transmission obtained by traditional testing and highlight the potential for crAssphage co-detection to improve interpretations of wastewater surveillance data.

1 February 2013 in Seminars in Liver Disease
Verified
Journal Article
Closed access
BKBrittany Kmush
Brittany Kmush
TWThomas Wierzba
Thomas Wierzba
LKLisa Krain
Lisa Krain
KNKenrad Nelson
Kenrad Nelson
ALAlain B. Labrique
Alain B. Labrique
Hepatitis E is an acute, viral hepatitis primarily transmitted through the fecal–oral route. The first major epidemic of hepatitis E virus (HEV) was reported in 1955 in Delhi, India. Since that time, numerous epidemics have been reported across the low- and middle-income countries in Asia and Africa. Even in the absence of large-scale outbreaks, hepatitis E is an important cause of clinical hepatitis. Serologic studies across Asia and Africa show a high prevalence of anti-HEV antibodies. Interest in hepatitis E has increased over the last two decades. However, there are many unanswered questions about the epidemiology of hepatitis E, including a low clinical illness rate in children and the high case fatality rate in pregnant women. Widespread usage of a hepatitis E vaccine may serve to relieve the burden of HEV disease in low- and middle-income countries in Africa and Asia.

1 May 2011 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
FLF. Eun-Hyung Lee
F. Eun-Hyung Lee
JHJessica L. Halliley
Jessica L. Halliley
EWEdward E Walsh
Edward E Walsh
AMAndrew P. Moscatiello
Andrew P. Moscatiello
BKBrittany L. Kmush
Brittany L. Kmush
ISIñaki Sanz
Iñaki Sanz
Surges of serum Abs after immunization and infection are highly specific for the offending Ag, and recent studies demonstrate that vaccines induce transient increases in circulating Ab-secreting cells (ASCs). These ASCs are highly enriched but not universally specific for the immunizing Ag, suggesting that a fraction of these ASCs could arise from polyclonal bystander stimulation of preexisting memory cells to unrelated Ags. This model is proposed to explain maintenance of long-lived serological memory in the absence of Ag exposure. To test this model, we measure the ability of respiratory syncytial virus and influenza virus infection or immunizations to influenza virus, tetanus toxoid, hepatitis B Ag, and human papillomavirus to stimulate bystander memory cells specific for other major environmental Ags that represent a large fraction of the preexisting memory B compartment. Bystander or nonspecific ASC responses to respiratory syncytial virus and tetanus could not be detected above the background levels in healthy adults, despite the presence of circulating memory B cells specific for the corresponding Ags. Nonspecific ASC responses in the healthy subjects and cord blood samples were similar. In contrast, both vaccination and infection induce massive expansion of circulating Ag-specific ASCs without significant increases in the frequencies of ASCs against unrelated Ags. Hence, nonspecific stimulation of memory B cells is unlikely to contribute to the mechanisms of long-term serological memory against major human pathogens. Additionally, high specificity of circulating ASCs after antigenic challenge highlights the diagnostic value of interrogating ASCs as an ideal single-time-point diagnostic immune surrogate for serology during acute infection.

7 May 2018 in Cold Spring Harbor Perspectives in Medicine
Verified
Journal Article
Closed access
PDF file
KNKenrad E. Nelson
Kenrad E. Nelson
ALAlain B. Labrique
Alain B. Labrique
BKBrittany L. Kmush
Brittany L. Kmush
Hepatitis E virus (HEV) genotypes 1 and 2 are responsible for the majority of acute viral hepatitis infections in endemic areas in South Asia and sub-Saharan Africa. In addition to frequent sporadic illnesses throughout the year, these viruses often cause large epidemics in association with monsoon rains in Asia or during humanitarian crises in Africa. Clinical hepatitis commonly involves adults more often than young children, with an overall mortality of ∼1%. However, the mortality among pregnant women is often 30% or higher. HEV infection in pregnant women frequently leads to infant mortality or premature delivery. Hepatitis E is an important, yet largely neglected, global public health problem.

1 September 2015 in Journal of Clinical Virology
Verified
Journal Article
Closed access
JIJacques Izopet
Jacques Izopet
ALAlain B. Labrique
Alain B. Labrique
BBBuddha Basnyat
Buddha Basnyat
HDHarry Dalton
Harry Dalton
BKBrittany Kmush
Brittany Kmush
DADinesh Adhikary
Dinesh Adhikary